Trial intelligence / Profile preview

Fresh motherwort capsule versus motherwort capsule for abnormal uterine bleeding (AUB-E, blood stasis syndrome)

ChiCTR1900027477Phase 4Not yet recruiting

Sponsor
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Start
Nov 2019
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of Motherwort in menstrual disorders (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: Blood routine examination, Routine urine test and 12 more. Planned start Nov 2019; status: not yet recruiting.

02

Drugs

Motherwort
03

Conditions

menstrual disorders

Beyond the preview

Go deeper on ChiCTR1900027477.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900027477.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call